A Method For The High Level Expression Of Active Lymphotoxin-Beta Receptor Immunoglobulin Chimeric Proteins And Their Purification

Patent No. EP2374872 (titled "A Method For The High Level Expression Of Active Lymphotoxin-Beta Receptor Immunoglobulin Chimeric Proteins And Their Purification") was filed by Biogen Idec MA on Dec 16, 1999. The application was issued on Feb 20, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TRUSCOTTAug 25, 2016ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2374872

BIOGEN IDEC MA
Application Number
EP10011212A
Filing Date
Dec 16, 1999
Status
Patent Maintained As Amended
Jan 18, 2019
Publication Date
Feb 20, 2019